News

Clinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2

The novel nitric oxide-donating bimatoprost eye drop is designed to lower IOP in patients with open-angle glaucoma or ocular hypertension

In a keynote speech, Warren Hoburg and Tyson J. Brunstetter, OD, PhD, will discuss in-orbit imaging and spaceflight-associated neuro-ocular syndrome

The Australia-based organisation is partnering with the UN Friends of Vision group for an event on 11 March

The encapsulated cell therapy from Neurotech Pharmaceuticals is the first FDA-approved treatment for MacTel

The toric IOLs demonstrated a slight advantage over FSAK and were associated with better postoperative uncorrected distance visual acuity

The modifier gene therapies from Ocugen target geographic atrophy and Stargardt disease

The authors said their results provide strong support that cultivated autologous limbal epithelial cell transplantation is safe and feasible

One in vitro study included in the manuscript was conducted in collaboration with researchers at the University of Southhampton in the United Kingdom

The investigators' findings suggest that CVI is a valuable noninvasive predictive biomarker for monitoring vascular changes in patients who smoke

The researchers reported a “notable” correlation which could serve as a predictive biomarker

In the group of new appointees, the organisation welcomed community members who are passionate about advocacy and education

This year, the European Society of Cataract and Refractive Surgeons has partnered with the Hellenic Society of Intraocular Implant and Refractive Surgery

More respondents reported experiencing sexual harassment than in a survey conducted 5 years earlier

The Visumax 800 boasts a faster laser pulse repetition rate for shorter procedures

The initiative marks the second annual ROP Awareness week, running from 24 February to 2 March, 2025

Researchers indicated that paediatric patients with Leber congenital amaurosis experienced improvements in vision

The biosimilar to aflibercept (Eylea) has already received approval in the EU and US

Francesco Bandello, MD, FEBO, discusses the Diabetic Eye Conditions Coalition and a five-point call to action

Italian investigators reported that ocular surface conditions such as dry eye disease are key factors in perioperative outcomes, even when patients achieve 20/20 vision

Voyager DSLT is already available in select markets in the EU and the UK, and reduces the specialised training required with manual selective laser trabeculoplasty

Risk factors vary in both short-term and long-term periods following Boston Type 1 keratoprosthesis surgery

According to Apellis and Sobi, pegcetacoplan (Aspaveli) first received marketing authorisation for treatment of paroxysmal nocturnal hemoglobinuria

Children experienced sudden vision loss, visual field constriction, nyctalopia and dyschromatopsia following febrile illness